A-1210477
CAS1668553-26-1
⚠ This product is for research use only, not for human or veterinary use.
We typically respond within 1 business day.
| CAS Number | 540737-29-9 |
| IUPAC Name | 2-hydroxypropane-1,2,3-tricarboxylic acid;3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile |
| Synonyms | Xeljanz; CP-690550 citrate; CP-690550-10; Tasocitinib citrate; Xeljanz Xr; Tasocitinib monocitrate |
| Molecular Weight | 504.50 g/mol |
| Molecular Formula | C22H28N6O8 |
| PubChem CID | 10174505 |
| SMILES | CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N.C(C(=O)O)C(CC(=O)O)(C(=O)O)O |
| Purity | >98% |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. |
Tofacitinib Citrate (CAS 540737-29-9) is the citrate salt form of tofacitinib, a selective Janus kinase (JAK) inhibitor with molecular formula C₂₂H₂₈N₆O₈ and MW 504.50 g/mol. It is also known as CP-690550 citrate, Tasocitinib citrate, and Xeljanz.
Tofacitinib is reported to act as a potent, ATP-competitive inhibitor of JAK1 and JAK3, with selectivity over JAK2 and TYK2 at standard assay concentrations. By blocking JAK-mediated phosphorylation of STAT proteins, it attenuates downstream cytokine signaling through the JAK-STAT pathway, particularly pathways driven by interleukins and interferons relevant to immune regulation.
Each batch is analyzed by HPLC and ¹H NMR, with a Certificate of Analysis provided on shipment. Available from milligram to kilogram scale, with flexible packaging to meet R&D and scale-up requirements.
All analytical documentation is provided free of charge with every order. Raw spectral data files (NMR, HPLC, LC-MS) are also available on request — just mention it in your enquiry.